Search - tctmd.com

Displaying 341 - 360 of 378

Sort: Relevancy | Date

Presentation NY Valves 2024

Pericardial Effusion After TAVR: Percutaneous Treatment Strategies

Presenter: Thomas E. Waggoner

June 05, 2024

Presentation NY Valves 2024

TAVR in a Patient With an Exophytic STJ Calcium Shelf Using a BEV and Two-Stage Inflation

Presenter: Keaton Nasser

June 05, 2024

Presentation NY Valves 2024

The Promise of Next Generation Cerebral Embolic Protection Devices

Presenter: Tamim M. Nazif

June 05, 2024

Presentation NY Valves 2024

Modern Era Clinical Trial Strategies For Cerebral Embolic Protection Devices

Presenter: Alexandra J. Lansky

June 05, 2024

Presentation NY Valves 2024

Practical Considerations for Post-TAVR Stroke Therapy

Presenter: Axel Linke

June 05, 2024

Presentation NY Valves 2024

Practical Tips for Cerebral Embolic Protection: From Clinical Trials to Clinical Practice

Presenter: Amar Krishnaswamy

June 05, 2024

Presentation NY Valves 2024

Trilogy TAVR in the Real World: An EU Implanter’s Experience with the Trilogy System

Presenter: Matti Adam

June 05, 2024

Presentation NY Valves 2024

Restoration of flow from CMR: Laminar Flow Impact on Outcomes

Presenter: Joao L. Cavalcante

June 05, 2024

Presentation NY Valves 2024

Insights of Disabling Stroke from the STS/ACC TVT Registry LBCT

Presenter: Neel Butala

June 05, 2024

Presentation NY Valves 2024

The Trilogy TAVR System and an Update on the ALIGN-AR Study

Presenter: Raj Makkar

June 05, 2024

Presentation NY Valves 2024

Hemodynamic Performance and Restoration of Laminar Flow

Presenter: Michael J. Reardon

June 05, 2024

Presentation NY Valves 2024

Options for a Lifetime and Long-Term Durability

Presenter: Ole De Backer

June 05, 2024

Presentation NY Valves 2024

Innovation in TAVR for Pure AR (J Valve)

Presenter: Tsuyoshi Kaneko

June 05, 2024

Presentation NY Valves 2024

Clinical Results with the DurAVR THV System

Presenter: Susheel K. Kodali

June 05, 2024

Presentation NY Valves 2024

Is Underdiagnosis of AR a Real Problem? Imaging Methods for the Evaluation of Aortic Regurgitation

Presenter: Vera Rigolin

June 05, 2024

Presentation NY Valves 2024

Understanding the Fundamentals of the ACURATE Platform

Presenter: Isaac George

June 05, 2024

Presentation NY Valves 2024

A New Class of TAVR, A New Design Target

Presenter: Christopher Meduri

June 05, 2024

Presentation NY Valves 2024

Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials

Presenter: Rebecca T. Hahn

June 05, 2024

Presentation NY Valves 2024

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Presenter: Neel Butala

June 05, 2024

Presentation NY Valves 2024

Predictors of Bioprosthetic Valve Dysfunction From the Randomized SMART Trial

Presenter: Howard C. Herrmann

June 05, 2024

Advertisement

Pericardial Effusion After TAVR: Percutaneous Treatment Strategies

TAVR in a Patient With an Exophytic STJ Calcium Shelf Using a BEV and Two-Stage Inflation

The Promise of Next Generation Cerebral Embolic Protection Devices

Modern Era Clinical Trial Strategies For Cerebral Embolic Protection Devices

Practical Considerations for Post-TAVR Stroke Therapy

Practical Tips for Cerebral Embolic Protection: From Clinical Trials to Clinical Practice

Trilogy TAVR in the Real World: An EU Implanter’s Experience with the Trilogy System

Restoration of flow from CMR: Laminar Flow Impact on Outcomes

Insights of Disabling Stroke from the STS/ACC TVT Registry LBCT

The Trilogy TAVR System and an Update on the ALIGN-AR Study

Hemodynamic Performance and Restoration of Laminar Flow

Options for a Lifetime and Long-Term Durability

Innovation in TAVR for Pure AR (J Valve)

Clinical Results with the DurAVR THV System

Is Underdiagnosis of AR a Real Problem? Imaging Methods for the Evaluation of Aortic Regurgitation

Understanding the Fundamentals of the ACURATE Platform

A New Class of TAVR, A New Design Target

Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Predictors of Bioprosthetic Valve Dysfunction From the Randomized SMART Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content